Avance Biosciences shares potency assay insights from TMC conference
Fade Gong, PhD, discussed regulatory frameworks and robust assay design strategies during a presentation at the TMC Innovation event in Houston.
See the latest news and media coverage for Avance Biosciences. We track all announcements, press releases, and industry mentions in real time, all in one place.
Contract research and testing organization for drug development
avancebio.comLast updated
In short: Avance Biosciences opened new Houston centers of excellence for potency and NGS testing, expanding its analytical services.
Fade Gong, PhD, discussed regulatory frameworks and robust assay design strategies during a presentation at the TMC Innovation event in Houston.
The role targets PhD scientists transitioning from research to commercial client-facing duties for biopharma partners.
The company successfully acquired, moved into, and qualified its new location at 5500 NW Central Drive, hosting an open house to thank employees and welcome partners.
The FDA released a webinar on its new guidance for evaluating genome editing safety in gene therapy products using next-generation sequencing methods.
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The 75,000-square-foot building ...
Avance Biosciences opened its new Potency and Cell-Based Assay Center of Excellence, a purpose-built facility designed to expand and centralize the company's capabilities in potency...
The NGS Center of Excellence was established to meet the growing demand for advanced, regulatory-ready sequencing methods. It brings together an expansive suite of platforms...
HOUSTON, Dec. 3, 2025 /PRNewswire/ -- Avance Biosciences today announced the opening of its new Potency and Cell-Based Assay Center of Excellence, a purpose-built facility...
Track Avance Biosciences and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Avance Biosciences and other trending companies.